Exploring new avenues to treat Alzheimer’s Dr Devendra Kumar, Mar 11, 2024 Dr Devendra Kumar, Assistant Professor, NMIMS SPTM Shirpur shares details of his study In funded by the ICMR. He informs that his…
US FDA grants breakthrough therapy designation to Roche’s anti-amyloid beta antibody gantenerumab EP News Bureau Oct 11, 2021 Gantenerumab is an investigational antibody in phase-III development for early Alzheimer's disease (AD)
